Retrospective Comparison of Targeted Anticancer Drugs Predicted by the CNS-TAP Tool Versus Those Selected by a Molecularly Driven Tumor Board in Children With DIPG

MLA

Roberts, Holly J., et al. “Retrospective Comparison of Targeted Anticancer Drugs Predicted by the CNS-TAP Tool Versus Those Selected by a Molecularly Driven Tumor Board in Children With DIPG.” Journal of Pediatric Hematology / Oncology, vol. 47, no. 1, Jan. 2025, pp. 19–30. EBSCOhost, https://doi.org/10.1097/MPH.0000000000002964.

APA

Roberts, H. J., Ravi, K., Marini, B. L., Schepers, A., Kline, C., Kilburn, L., Prados, M., Byron, S. A., Sturza, J., Mueller, S., Koschmann, C., & Franson, A. T. (2025). Retrospective Comparison of Targeted Anticancer Drugs Predicted by the CNS-TAP Tool Versus Those Selected by a Molecularly Driven Tumor Board in Children With DIPG. Journal of Pediatric Hematology / Oncology, 47(1), 19–30. https://doi.org/10.1097/MPH.0000000000002964

Chicago

Roberts, Holly J., Karthik Ravi, Bernard L. Marini, Allison Schepers, Cassie Kline, Lindsay Kilburn, Michael Prados, et al. 2025. “Retrospective Comparison of Targeted Anticancer Drugs Predicted by the CNS-TAP Tool Versus Those Selected by a Molecularly Driven Tumor Board in Children With DIPG.” Journal of Pediatric Hematology / Oncology 47 (1): 19–30. doi:10.1097/MPH.0000000000002964.